ArticlePCN reports : psychiatry and clinical neurosciences2025
Exploratory study of dual-task digital device in children and adolescents with attention-deficit/hyperactivity disorder.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Multimodal Digital Therapeutics Enhanced by Task Design and AI for Attention-Deficit/Hyperactivity Disorder Core Symptoms and Executive Functions in Children and Adolescents: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.Journal of medical Internet research · 2026Pooled it
- A Preliminary Study on the Efficacy and Safety of a Novel Digital Therapeutic Device: A Randomized Clinical Trial in South Korean Pediatric Patients With Attention-Deficit/Hyperactivity Disorder.Psychiatry investigation · 2026Article
- Multicenter randomized trial of a digital therapeutic game for executive function in children with ADHD.NPJ digital medicine · 2026Article
- Exploratory study of dual-task digital device in children and adolescents with attention-deficit/hyperactivity disorder.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: The study aimed to assess the efficacy and safety of SDT-001, a digital therapeutic, in Japanese children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Methods: This phase 2, multicenter, randomized, double-blind, sham-controlled study (jRCT1080225158) was conducted for a duration of up to 14 weeks. After screening, eligible participants were randomized to receive SDT-001 or single-task intervention for 25 min/day for 6 weeks and followed for 4 weeks after the intervention. A post hoc analysis was also performed to compare the effects of SDT-001 or a single-task to a nonrandomized, open-labeled, observational group (as the reference follow-up group; without single- or dual-task training; and continuing psychosocial treatment, including environmental adjustment). Results: Overall, 262 participants were enrolled in the study between July 2020 and July 2021. Of these, 261 participants were included in the analysis (SDT-001, Conclusion: These findings suggest SDT-001 as a promising treatment option, addressing the challenges of psychosocial treatment and pharmacotherapy in Japanese children and adolescents with ADHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.